Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CROWN: Withdrawal of mesalazine in Crohn's disease remission
2009-011220-62Phase 4Terminated
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Salcrozine in Crohn's disease (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Effect of stopping mesalazine on maintenance of remission and Effect of stopping mesalazine on quality of life. Started Jul 2009; status: terminated.
02
Drugs
Salcrozine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2009-011220-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011220-62.